CN Patent

CN107530348A — 一种含有jak激酶抑制剂或其可药用盐的药物组合物

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2018-01-02 · 8y expired

What this patent protects

本发明提供了一种含有JAK激酶抑制剂或其可药用盐的药物组合物。具体而言，本发明提供了一种药物组合物，含有(3aR,5s,6aS)‑N‑(3‑甲氧基‑1,2,4‑噻二唑‑5‑基)‑5‑(甲基(7H‑吡咯并[2,3‑d]嘧啶‑4‑基)氨基)六氢环戊并[c]吡咯‑2(1H)‑甲酰胺或其可药用盐和纤维素醚。本发明的药物组合物具有溶出迅速、稳定性良好的特点。

USPTO Abstract

本发明提供了一种含有JAK激酶抑制剂或其可药用盐的药物组合物。具体而言，本发明提供了一种药物组合物，含有(3aR,5s,6aS)‑N‑(3‑甲氧基‑1,2,4‑噻二唑‑5‑基)‑5‑(甲基(7H‑吡咯并[2,3‑d]嘧啶‑4‑基)氨基)六氢环戊并[c]吡咯‑2(1H)‑甲酰胺或其可药用盐和纤维素醚。本发明的药物组合物具有溶出迅速、稳定性良好的特点。

Drugs covered by this patent

Patent Metadata

Patent number
CN107530348A
Jurisdiction
CN
Classification
—
Expires
2018-01-02
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hengrui Medicine Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.